Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC3107 (BCG Vaccine) in Healthy Infants
NCT03947138Phase 3Completed
- Sponsor
- GC Biopharma
- Start
- Aug 2019
- Primary completion
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of GC3107A in Tuberculosis (TB), sponsored by GC Biopharma. Started Aug 2019; status: completed.
02
Drugs
GC3107A
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03947138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03947138.